Skip to main content
Egyptian Rheumatology and Rehabilitation

Table 2 Disease activity before and after HCQ shortage

From: Hydroxychloroquine non-availability during COVID-19 pandemic and its relation to anxiety level and disease activity in rheumatoid arthritis and lupus patients: a cross-sectional study

 

Before shortage

After shortage

Paired t test

P value

CDAI in RA patients

11.47 ± 5.62

12.51 ± 5.97

1.86

0.063

SELENA in SLE patients

4.86 ± 3.78

5.88 ± 4.11

1.86

0.064

  1. CDAI clinical disease activity index, RA rheumatoid arthritis, SELENA safety of estrogens in systemic lupus erythematosus national assessment, SLE systemic lupus erythematosus
  2. *Significant P value if p < 0.05
Back to article page